LGND Latest Quarter’s Earnings
Announce Date10/29/2026
EPS Actual (USD)-1.43
Revenue Actual (USD)149.03M
Ligand Pharmaceuticals Inc Earnings Dates & Reports
This page offers detailed Ligand Pharmaceuticals Inc earnings data including the latest Ligand Pharmaceuticals Inc earnings report, the upcoming Ligand Pharmaceuticals Inc earnings date, historical data and Ligand Pharmaceuticals Inc earnings call news.
LGND Upcoming Quarter's Earnings
Announce Date--
EPS Forecast (USD)--
Revenue Forecast (USD)--
LGND FY2025 Earnings
EPS (YoY)6.132881.81%
Revenue (YoY)215.01M28.65%
Ligand Pharmaceuticals Inc (LGND) Earnings History
| Release Date | Period End | EPS/Forecast | Revenue/Forecast | EPS Surprise % | Revenue Surprise % |
|---|---|---|---|---|---|
| 10/29/2026 | 09/2026 | -1.43/2.38 | 149.03M/77.23M | -159.92% | 92.96% |
| 8/6/2026 | 06/2026 | 2.42/1.82 | 63.69M/60.76M | 32.50% | 4.82% |
| 5/7/2026 | 03/2026 | -0.67/1.82 | 51.72M/58.70M | -136.97% | -11.88% |
| 2/26/2026 | 12/2025 | 2.21/1.56 | 59.67M/55.59M | 41.33% | 7.33% |
| 11/6/2025 | 09/2025 | 5.99/1.93 | 115.46M/58.79M | 211.06% | 96.38% |
| 8/7/2025 | 06/2025 | 0.25/1.42 | 47.63M/43.87M | -82.36% | 8.56% |
| 5/8/2025 | 03/2025 | -2.21/1.21 | 45.33M/38.70M | -282.56% | 17.13% |
| 2/27/2025 | 12/2024 | -1.64/1.19 | 42.81M/39.02M | -237.66% | 9.71% |
Ligand Pharmaceuticals Inc Latest Earnings Call Transcripts
Ligand (LGND) Q3 2026 Earnings Call: Royalty Revenue Rises 51%, EPS Guidance Raised
Ligand’s Q3 2026 earnings call covered 51% royalty revenue growth, Filspari momentum, the XOMA portfolio and higher adjusted EPS guidance.